Clinical Trials Browser

Phase 2 × Carcinoma, Transitional Cell × Oxaliplatin × Clear all

NCT04039867 2023-08-21

Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer

Phase 2 Terminated

17 enrolled 9 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell